Feasibility Testing of the Quality-monitoring Tool, Qdact, for the Palliative Care Research Cooperative
NCT ID: NCT02411305
Last Updated: 2016-02-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Elaboration of a Multi-dimensional Indicator of Quality in Palliative Care
NCT02814682
A Multidimensional Strategy to Improve Quality of Life of Patients With Multiple Symptoms and Palliative Care Needs
NCT03665168
Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer
NCT05113199
Palliative Care Intervention in Improving Symptom Control and Quality of Life in Patients With Stage II-IV Non-small Cell Lung Cancer and Their Family Caregivers
NCT02243748
Implementing Spiritual Care in Inpatient Palliative Care
NCT06206551
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In palliative care, for example, it is usually considered best practice to prescribe opioids for moderate/severe pain. Imagine that a palliative care program's calculated adherence rate reveals that their clinicians prescribe opioids for moderate-to-severe pain only 50% of the time. Armed with this information, the program can now develop a directed quality improvement project with the intention of improving this performance towards a more ideal goal (e.g. 75%). Further, it can provide feedback to clinicians in real-time regarding how they are performing against the quality measures of interest. In this example, clinicians may receive an electronic alert reminding them to prescribe an opioid when directed by an accepted best practice. This real-time approach, combined with a system that promotes culture of data collection, sharing, benchmarking, and reporting, are effective methods to improve healthcare quality. Lastly, and the focus of this proposal, is to build and test such an infrastructure that performs such real-time quality monitoring of healthcare measures in the Palliative Care Research Cooperative group (PCRC).
The investigators have previously identified the three major components needed for an effective and usable quality-monitoring infrastructure. Together, these three components answer the "what", "how", and "for why" questions that must be addressed within a quality assessment and improvement system.
First, is the ability to perform collaborative and integrated data collection across several sites. Successful multi-site data collection requires a centrally governed set of data collection processes, which are guided by a data dictionary. A data dictionary is a set of agreed-upon data elements, answer choices, rules, and branching logic. The data dictionary informs the development of a data collection platform for use by clinicians. Together, the data dictionary and software for use by clinicians guide "what" data is collected, and ensure that the intended collaborative analyses can be performed with the data set created.
Second, is the process for data collection - the "how" characteristic within the system. Data is collected, transmitted and recorded through the use of a data collection platform, transmission processes, and registry, respectively. The data collection platform is the interface in which real-time data is captured and recorded. This can involve paper-based or electronic forms using patient, caregiver, or clinician reporters. Data is then transmitted to the registry, either through electronic or manual means. Lastly, data is collected and securely stored in a prospective registry, so quality reports can be generated and research analyses completed. These steps are recommended standards for development of health information technology by the Agency for Healthcare Research and Quality (AHRQ).
Third, is the component of the infrastructure that answers the question, "for why?" Several reports have highlighted the need to translate raw data from quality monitoring efforts into continuous feedback on quality to clinicians and other end-users to motivate the delivery of best practices. This allows for changes in clinician performance during usual clinical care delivery, thus meeting the Institute of Medicine's aim for a rapid learning healthcare system. Generally, feedback is provided through system-generated reports that target specific end-users (e.g. clinicians, administrators) delivered during pre-specified time periods (e.g. weekly, quarterly).
At Duke University, investigators recently built the information technology infrastructure needed for prospective quality measure adherence and outcomes monitoring in palliative care. This system was developed and deployed in the Carolinas Consortium for Palliative Care, a four-site collaboration between Duke University and three community palliative care organizations. Recently, this Consortium has expanded to include organizations outside the Carolinas; eleven sites now comprise the Global Palliative Care Quality Alliance (GPCQA). The rapid expansion of qdact users and subsequent data collected have supported several research-level analysis published in the literature.
In using qdact.pc, clinicians record data on processes of care and patient-reported outcomes on personal iPadsĀ® during face-to-face clinical encounters with patients. During patient interviews, clinicians record patient-reported areas of distress, clinical management decisions, and patient-reported outcomes using validated instruments. These instruments include those common to the field, including the Edmonton Symptom Assessment Scale (ESAS), Palliative Performance Scale, and FACT-G. Longitudinal changes in these scales are captured through repeat use of qdact.pc during subsequent encounters. Further, qdact.pc calculates length of stay from admission and discharge dates, changes in symptom severity by calculating the difference between two dates, and readmission rates by analyzing whether patients in the registry had previously been admitted. Then, care processes and outcomes can be linked using these data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PCRC Palliative Care Clinicians
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agency for Healthcare Research and Quality (AHRQ)
FED
Palliative Care Research Cooperative Group
NETWORK
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCSF
San Francisco, California, United States
University of Colorado
Aurora, Colorado, United States
University of North Carolina
Chapel Hill, North Carolina, United States
Duke University Medical Center
Durham, North Carolina, United States
Four Seasons Compassion for Life
Flat Rock, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00060336
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.